✨ Free AI Report
Proscia Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Proscia Inc.
Company Research

Proscia Inc.: Business Overview, Financials & Competitive Analysis

Proscia Inc. scores 8/10 on the AskCyborg Cyborg Score (Strong). Proscia is a well-positioned, fast-growing digital pathology leader capturing outsized demand from precision medicine adoption in biopharma and diagnostics. Proscia more than doubled its growth in 2024, validated by customer adoption among top-tier pharma and diagnostic labs. The company has FDA 510(k) clearance and CE-IVDR certification for its diagnostic software.

What is Proscia Inc.'s industry? Proscia Inc. (proscia.com) operates in Diagnostic Laboratories. AskCyborg classifies Proscia Inc. under Diagnostic Laboratories in its company registry.

Proscia is a software company accelerating pathology's transition to a digital, data-driven discipline and enabling AI to advance precision medicine, with its Concentriq enterprise pathology platform, precision medici...

8/ 10Strong

Cyborg Score thesis

Proscia is a well-positioned, fast-growing digital pathology leader capturing outsized demand from precision medicine adoption in...

Read the full analyst-debate transcript →
Industry Diagnostic Laboratories
5 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Proscia Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Proscia Inc.

AskCyborg analysts argue the bull and bear cases for Proscia Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Proscia Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Proscia Inc. Overview

Pro stress-test →

Proscia is a software company accelerating pathology's transition to a digital, data-driven discipline and enabling AI to advance precision medicine, with its Concentriq enterprise pathology platform, precision medicine AI portfolio, and real-world data fueling the development and use of novel therapies and diagnostics. 14 of the top 20 pharmaceutical companies and a global network of diagnostic laboratories rely on Proscia's solutions.

Strategic Profile

Pro stress-test →

Proscia is biopharma's partner of choice to put pathology AI into practice. The company leverages an open-architecture platform that integrates AI solutions across drug discovery, clinical trials, companion diagnostics, and diagnostics labs, positioning it at the intersection of precision medicine and digital transformation in pathology.

Competitive Landscape

Pro stress-test →

Proscia was named as Leader among 15 other companies, including Philips, Ibex, and PathAI. Direct competitors in AI-powered digital pathology include PathAI (focused on machine learning-driven diagnosis), 4D Path, Techcyte, Imagene AI, Qritive, and Pathology Watch, but Proscia's scale advantage (serving 14 of top 20 pharma) and open-architecture integration strategy differentiate its positioning.

Industry Context

Proscia Inc. operates in Diagnostic Laboratories.

Key facts

Founded: 2014 · Headquarters: Philadelphia, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Proscia Inc..

  • Proscia more than doubled its growth in 2024, signaling strong market traction
  • 14 of the top 20 pharmaceutical companies rely on Proscia's solutions, representing highly sticky enterprise concentration
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • May 2026Proscia honored alongside IQVIA, Medidata, and Thermo Fisher Scientific
  • January 2025Proscia more than doubled growth in 2024, cemented leadership position with life sciences organizations and diagnostic laboratories increasingly deploying Concentriq
  • +1 moreTrack every material event for Proscia Inc. as it happens. Explore monitoring →
Get alerted when Proscia Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

PathAIAI-powered pathology platform for cancer diagnosis using machine learning→IbexAI solutions for pathology and diagnostics→Philips Digital PathologyDigital pathology solutions and imaging systems→4D PathDigital pathology image analysis→TechcyteDigital pathology and computational analysis→

Compare Proscia Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Proscia Inc. operates in Diagnostic Laboratories. See how the rest of the sector scores on the Cyborg framework.

Browse Diagnostic Laboratories research →
NEW · MCP server

Ask your AI assistant about Proscia Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Proscia Inc. and its top competitor on Cyborg Score”
“What did Proscia Inc. do this quarter?”
“Is Proscia Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Proscia Inc. do?+
Proscia is a software company accelerating pathology's transition to a digital, data-driven discipline and enabling AI to advance precision medicine, with its Concentriq enterprise pathology platform, precision medici...
What is Proscia Inc.'s Cyborg Score?+
Proscia Inc. has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Proscia Inc.'s main competitors?+
Named competitors include PathAI, Ibex, Philips Digital Pathology, 4D Path. The full competitive landscape is in the AskCyborg report.
How can I get the full Proscia Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Proscia Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Proscia Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Diagnostic Laboratories research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7IBEX Limited